CIS
KRTX

Capital International Sarl’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Capital International Sarl’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,624
Closed -$6.21M – 259
2023
Q4 		$6.21M Buy
19,624
+9,759
+99% +$1.9M 0.23% 104
2023
Q3 		$1.67M Buy
9,865
+627
+7% +$118K 0.08% 180
2023
Q2 		$2M Buy
+9,238
New +$1.98M 0.09% 178

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Capital International Sarl's KRTX Position: Q1 2024 in Review

Capital International Sarl sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 19,624 shares — an estimated $6.21M sold.

Capital International Sarl first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $6.21M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Capital International Sarl reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Capital International Sarl sold 19,624 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.21M.
  • Capital International Sarl first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Capital International Sarl's Karuna Therapeutics, Inc. Common Stock position peaked at $6.21M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Capital International Sarl's 13F filing for Q1 2024, filed 14 May 2024.